Equibles does not estimate personal net worth.
Earlier roles on record: CFO at Insulet Corp (PODD) until October 20, 2023. Insulet Corp reported in an 8-K filed October 3, 2023 that Wayde McMillan resigned as Executive Vice President, Chief Financial Officer and Treasurer, effective October 20, 2023. Wayde McMillan has spoken on 14 earnings calls across 1 company, most recently for Insulet Corp on August 8, 2023. The companies whose calls Wayde McMillan spoke on are classified in the Healthcare sector.
“On September 29, 2023, Wayde McMillan, the Executive Vice President, Chief Financial Officer and Treasurer of Insulet Corporation (the "Company") informed the Company of his decision to resign from such position, effective October 20, 2023.”
“We delivered another strong quarter of financial performance and strategic progress and once again delivered record U.S. and global new customer starts. We generated 32% revenue growth in Q2, finishing above the high end of our guidance range.”
“First quarter results exceeded our expectations and we made further strategic progress. We delivered record U.S. and global new customer starts for any Q1. And in the U.S., they were the second highest of all time, slightly below last quarter’s record.”
“2022 was an exciting year with the U.S. launch of Omnipod 5 and the fourth quarter was no exception. We once again delivered strong financial results while advancing our mission.”
“Q3 marked another record-breaking quarter. Our global team continues to execute at a high level, and Omnipod 5 is proving to be a life-changing new option for people with diabetes.”
“We’ve made great progress in Q2 as we delivered another quarter of record US and global new customer starts and achieved a number of notable milestones, including the US full commercial launch of Omnipod 5 within the time range we expected.”
Start not stated–2023-10-20
PODD
Medical Devices · Healthcare
CFO
